CANSINO BIOLOGICS INC revenue breakdown overview

CANSINO BIOLOGICS INC revenue for the last year amounted to 345.18 M CNY, the most of which — 357.08 M CNY — came from its highest performing source at the moment, Vaccine Products, the year earlier bringing 1.03 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought CANSINO BIOLOGICS INC 342.03 M CNY, and the year before that — 812.76 M CNY.